Introduction {#Sec1}
============

The genera *Chryseobacterium* and *Elizabethkingia* are aerobic, nonfermenting, nonmotile, catalase-positive, oxidase-positive, indole-positive, and gram-negative bacilli that are distributed in soil and water environments^[@CR1],[@CR2]^. These microorganisms were recently been reported as agents that cause life-threatening pneumonia, bacteremia, meningitis, and neutropenic fever in humans, especially immunocompromised patients^[@CR1]--[@CR5]^.

Both *Chryseobacterium* and *Elizabethkingia* were historically derived from the genus *Flavobacterium*. To date, more than 90 species are included in the genus *Chryseobacterium*. Among these, *C*. *indologenes* is the most common cause of human infections^[@CR1],[@CR5]^. Human infections caused by other *Chryseobacterium* species, such as *C*. *gleum*, are rarely reported^[@CR6]^. Currently, the genus *Elizabethkingia* includes three species, including *E*. *meningoseptica*, *E*. *miricola*, and *E*. *anophelis* ^[@CR7]^. Among these species, *E*. *meningoseptica* is the most well-known species that causes opportunistic infections in immunocompromised patients^[@CR2]--[@CR4]^. However, *Elizabethkingia anophelis* has recently emerged as a cause of life-threatening infections and has triggered several outbreaks of infections in Africa^[@CR8]^, Singapore^[@CR9]^, Hong Kong^[@CR10]^, and the USA^[@CR11],[@CR12]^.

Several methods have been developed to identify microorganisms. These include biochemical methods, 16S rRNA gene sequencing, multiple molecular marker sequencing, and protein fingerprinting techniques (for example, matrix-assisted laser desorption ionization--time of flight mass spectrometry; MALDI-TOF MS). Occasional studies have reported misidentifying *Chryseobacterium* and *Elizabethkingia* species when using conventional phenotypic identification systems and the VITEK 2 Automated Identification System (bioMérieux, Marcy l'Etoile, France)^[@CR6],[@CR10],[@CR13]^. However, 16S rRNA gene sequencing has been shown to be a reliable method of identifying *Chryseobacterium* and *Elizabethkingia* species^[@CR14],[@CR15]^. In this study, we used 16S rRNA sequencing to analyze *Chryseobacterium* and *Elizabethkingia* species isolated from patient blood samples. We compared the accuracies of the following four bacterial identification systems that are commonly used to identify *Chryseobacterium* and *Elizabethkingia* species: (1) API/ID32 Phenotyping Kits (bioMérieux, Marcy l'Etoile, France), (2) Phoenix 100 ID/AST Automated Microbiology System (Becton Dickinson Co., Sparks, MD, USA), (3) VITEK 2 Automated Identification System, and (4) VITEK MS MALDI-TOF MS System (bioMérieux, Marcy l'Etoile, France).

Results {#Sec2}
=======

Isolates and claimed microorganisms in databases of identification systems {#Sec3}
--------------------------------------------------------------------------

A total of 114 consecutively non-repeated isolates that were initially identified as *Chryseobacterium* and *Elizabethkingia* species by a clinical microbiology laboratory were included in this study (Table [1](#Tab1){ref-type="table"}). According to BLAST results based on 16S rRNA gene sequencing, 36 isolates were *C*. *indologenes* (31.6%), 35 were *E*. *anophelis* (30.7%), 22 were *C*. *gleum* (19.3%), 13 were *E*. *meningoseptica* (11.4%), 3 were *C*. *culicis*, 2 were *C*. *bemardetii*, 2 were *Candidatus Chryseobacterium massilia*, and 1 was *E*. *miricola*. The coverage rates of these *Chryseobacterium* and *Elizabethkingia* species that were obtained using the API/ID32, Phoenix 100 ID/AST, VITEK 2, and VITEK MS v2.0/v3.0 identification databases are shown in Table [1](#Tab1){ref-type="table"}. *Chryseobacterium indologenes* and *E*. *meningoseptica* were claimed in the databases of all biochemical systems and MALDI-TOF MS systems. *C*. *gleum* was built into all systems except API/ID32. *Elizabethkingia miricola* was included only in the Phoenix 100 ID/AST database. However, these identification systems did not contain identification data for *Candidatus C*. *massilia*, *C*. *bemardetii*, *C*. *culicis*, and *E*. *anophelis*.Table 1The manufacturers' listed coverage of databases and identification of *Chryseobacterium* and *Elizabethkingia* species by API/ID32, Phoenix 100 ID/AST, VITEK 2, and VITEK MS.16S rRNA sequence-based identification (no. of isolates)Identification method (no. of isolates)API/ID32 v3.1Phoenix 100 ID/AST v5.51AVITEK 2 v7.01VITEK MS Knowledge Base v2.0/v3.0Strain name (no. of isolates)Database CoverageCorrect rate (%)Strain name (no. of isolates)Database CoverageCorrect rate (%)Strain name (no. of isolates)Database CoverageCorrect rate (%)Strain name (no. of isolates)Database CoverageCorrect rate (%)*Chryseobacterium* species (65)55.453.856.953.8*Candidatus C*. *massilia* (2)*C*. *indologenes* (2)No0*Sphingomonas paucimobilis* (2)No0*C*. *indologenes* (1) Genus *Brevundimonas* (1)No0*C*. *indologenes* (2)No0*C*. *bemardetii* (2)*C*. *indologenes* (2)No0*C*. *indologenes* (1) *Bergeyella zoohelcum* (1)No0*C*. *indologenes* (2)No0Genus *Chryseobacterium* (1) No identification (1)No0*C*. *culicis* (3)*E*. *meningoseptica* (1) *C*. *indologenes* (2)No0*C*. *indologenes* (2) *Bergeyella zoohelcum* (1)No0*C*. *indologenes* (3)No0*C*. *indologenes* (2) No identification (1)No0*C*. *gleum* (22)*C*. *indologenes* (18) Genus *Chryseobacterium* (1) No identification (3)No0*C*. *gleum* (1) *C*. *indologenes* (14) *Bergeyella zoohelcum* (7)Yes4.5*C*. *gleum* (1) *C*. *indologenes* (21)Yes4.5*C*. *indologenes* (19) No identification (3)Yes0*C*. *indologenes* (36)*C*. *indologenes* (36)Yes100*C*. *indologenes* (34) *Bergeyella zoohelcum* (2)Yes94.4*C*. *indologenes* (36)Yes100*C*. *indologenes* (35) No identification (1)Yes97.2*Elizabethkingia* species (49)24.524.526.526.5*E*. *anopheles* (35)*E*. *meningoseptica* (26) No identification (2)No0*E*. *meningoseptica* (35)No0*E*. *meningoseptica* (35)No0*E*. *meningoseptica* (35)No0*E*. *meningoseptica* (13)*E*. *meningoseptica* (12) No identification (1)Yes92.3*E*. *meningoseptica* (12) *Empedobacter brevis* (1)Yes92.3*E*. *meningoseptica* (13)Yes100*E*. *meningoseptica* (13)Yes100*E*. *miricola* (*1*)*E*. *meningoseptica* (1)No0*E*. *meningoseptica* (1)Yes0*E*. *meningoseptica* (1)No0*E*. *meningoseptica* (1)No0Quality control strain*C*. *indologenes* BCRC 17271*C*. *indologenes*Yes100*C*. *indologenes*Yes100*C*. *indologenes*Yes100*C*. *indologenes*Yes100*E*. *meningoseptica* BCRC 10677*E*. *meningoseptica*Yes100*E*. *meningoseptica*Yes100*E*. *meningoseptica*Yes100*E*. *meningoseptica*Yes100

API/ID32 Phenotyping Kits {#Sec4}
-------------------------

The API/ID32 system correctly identified all isolates of *C*. *indologenes* (36/36) and 92.3% (12/13) of *E*. *meningoseptica* isolates (Table [1](#Tab1){ref-type="table"}). Eighteen of 22 *C*. *gleum* (81.8%) were misidentified as *C*. *indologenes*. Six of 7 rarely observed *Chryseobacterium* (including *Candidatus C*. *massilia*, *C*. *bemardetii*, and *C*. *culicis*) were recognized as *C*. *indologenes*, and the seventh was identified as *E*. *meningoseptica*. The majority (94.4%) of *E*. *anophelis* and *E*. *miricola* were identified as *E*. *meningoseptica*. The overall correct rates of identification of *Chryseobacterium* and *Elizabethkingia* species when using API/ID32 were 55.4% and 24.5%, respectively.

Phoenix 100 ID/AST Automated Microbiology System {#Sec5}
------------------------------------------------

Among the 36 isolates of *C*. *indologenes*, 34 (94.4%) were correctly identified. However, only 4.5% (1/22) of *C*. *gleum* were successfully diagnosed. No *Candidatus C*. *massilia*, *C*. *bemardetii*, and *C*. *culicis* were recognized (Table [1](#Tab1){ref-type="table"}). The accuracy rate when identifying *Chryseobacterium* species was 53.8%. For the genus *Elizabethkingia*, 92.3% (12/13) of *E*. *meningoseptica* were accurately identified. However, the other two species, *E*. *anophelis* and *E*. *miricola*, were misdiagnosed as *E*. *meningoseptica*. The rate of successful identification of *Elizabethkingia* species was only 24.5% when using the Phoenix 100 ID/AST Automated Microbiology System.

VITEK 2 Automated Identification System {#Sec6}
---------------------------------------

All *C*. *indologenes* (n = 36) were reliably identified when using VITEK 2 (Table [1](#Tab1){ref-type="table"}). However, 4.5% (1/22) of *C*. *gleum* species were correctly identified, and the remaining 95.5% (21/22) were misidentified as *C*. *indologenes*. All *C*. *bemardetii* and *C*. *culicis* isolates were identified as *C*. *indologenes*. Of the *Elizabethkingia* species, all *E*. *meningoseptica* (13/13) were successfully identified, but the remaining three species were misidentified as *E*. *meningoseptica*. The accuracy of this method for identifying *Chryseobacterium* and *Elizabethkingia* species was 56.9% and 26.5%, respectively.

VITEK MS MALDI-TOF MS System {#Sec7}
----------------------------

Of the *Chryseobacterium* species, 97.2% (35/36) of *C*. *indologenes* isolates were correctly identified. However, no *Candidatus C*. *massilia*, *C*. *bemardetii*, or *C*. *culicis* isolates were successfully recognized (Table [1](#Tab1){ref-type="table"}). The overall rate at which this method correctly identified *Chryseobacterium* species was 53.8%. Of the *Elizabethkingia* species, all *E*. *meningoseptica* (13/13, 100%) were correctly identified. However, all *E*. *anophelis* and *E*. *miricola* were misidentified as *E*. *meningoseptica*. The accuracy rate of this method when identifying *Elizabethkingia* species was only 26.5%.

Discussion {#Sec8}
==========

In this study, we compared the accuracies of four commercial microbial identification systems to that of 16S rRNA gene sequencing for identifying *Chryseobacterium* and *Elizabethkingia* species. The overall concordance between each of these four commercial methods and 16S rRNA gene sequencing for identifying *Chryseobacterium* and *Elizabethkingia* species were as follows: API/ID32, 42.1%; Phoenix 100 ID/AST, 41.2%; VITEK 2, 43.9%; and VITEK MS, 42.1%. After taking the coverage of each database into account, the overall concordance between 16S rRNA gene sequencing and API/ID32, Phoenix 100 ID/AST, VITEK 2, and VITEK MS was 98%, 75.8%, 70.4%, and 67.6%, respectively.

*Chryseobacterium gleum* is rarely reported to cause infection in humans^[@CR16],[@CR17]^. However, our data reveal that *C*. *gleum* accounts for 33.8% of *Chryseobacterium* bacteremia cases in humans. Lo *et al*.^[@CR6]^ reported that 15 clinical isolates of *C*. *gleum* that were confirmed by 16S rRNA gene sequencing were misidentified by VITEK 2 as *C*. *indologenes* (14/15; 93.3%) and *E*. *meningoseptica* (1/15; 6.7%). When submitted to a Bruker Microflex LT MALDI-TOF MS System using Biotyper database 3.0 (Bruker Daltonics, Bremen, Germany), 2 (13.3%) and 13 (86.6%) of these 15 isolates were identified as *C*. *gleum* species and probable species, respectively. In our study, 81.8% of *C*. *gleum* isolates were misidentified as *C*. *indologenes* by all four commercial identification systems. *Chryseobacterium gleum* was included in the Phoenix 100 ID/AST, VITEK 2, and VITEK MS (v2.0 and v3.0) databases but not in the API/ID32 database. Among the 22 *C*. *gleum* isolates in our study, only 1 (4.5%) was correctly identified by VITEK 2 and Phoenix 100 ID/AST, and none were accurately recognized by VITEK MS. MALDI-TOF MS systems have become popular in clinical microbiology laboratories because they rapidly, highly accurately, and cost-effectively identify different microorganisms. However, despite the fact that *C*. *gleum* was included in the spectral database, none of the *C*. *gleum* isolates were accurately identified by VITEK MS. The four microbial identification systems used in our study are widely used by clinical microbiology laboratories all over the world. The inability of these techniques to distinguish *C*. *gleum* from *C*. *indologenes* may result from false impressions that have led to the notion that there is a low prevalence of *C*. *gleum* and an overestimation of the prevalence of *C*. *indologenes* infections in humans.

Recent studies have shown that *E*. *anophelis* is frequently misidentified as *E*. *meningoseptica* ^[@CR8]--[@CR10]^. Lau *et al*.^[@CR10]^ reported 17 patients in Hong Kong who were diagnosed using 16S rRNA gene sequencing with infection with *E*. *anophelis*. However, all 17 *E*. *anophelis* isolates were recognized as *E*. *meningoseptica* by VITEK 2, and the Bruker MALDI-TOF MS Biotyper also failed to correctly identify *E*. *anophelis* ^[@CR10]^. Similar to a report by Lau *et al*., Han *et al*.^[@CR13]^ found in their study performed in South Korea that none of the tested 51 *E*. *anophelis* isolates was correctly identified by a Bruker MALDI-TOF MS Biotyper. A VITEK MS research-use-only (RUO) system coupled with a SARAMIS SuperSpectra database successfully identified all 51 *E*. *anophelis* isolates^[@CR13]^, but this system is not available to clinical microbiology laboratories. In our study, 55.5% (27/49) of previously identified *E*. *meningoseptica* were revealed to be *E*. *anophelis* based on the results of 16S rRNA gene sequencing. Our results show that using VITEK MS with the v2.0 and v3.0 Knowledge Bases or any of the other three commonly used biochemical systems discussed here resulted in the failed identification of *E*. *anophelis*. We suggest that many previously reported *E*. *meningoseptica* infections might in fact have been identified as *E*. *anophelis* if they were analyzed using commercial identification systems. The prevalence of *E*. *anophelis* infections in humans could therefore be dramatically underestimated.

Conclusions {#Sec9}
===========

Being able to correctly identify microorganisms is extremely important in clinical practice and microbiologic research. However, the results of our study show that four microbial identification systems that are widely used in clinical microbiology laboratories are highly inaccurate when identifying *Chryseobacterium* and *Elizabethkingia* species. Specifically, the extremely low rates at which these methods identify the life-threatening pathogens *C*. *gleum* and *E*. *anophelis* may cause the prevalence of these species to be substantially underestimated. We recommend amending the method used to discriminate *C*. *gleum* from *C*. *indologenes* and adding a database for *E*. *anophelis* to the microbial identification systems discussed here.

Materials and Methods {#Sec10}
=====================

Ethics and experimental biosafety statements {#Sec11}
--------------------------------------------

This study was approved by the Institutional Review Board of E-Da Hospital (EMRP-105--134). The need for patient informed consent was waived by the Institutional Review Board of E-Da Hospital because the retrospective analysis of routine blood cultures posed no more than a minimal risk of harm to the subjects. The experiments in this study were approved by the Institutional Biosafety Committee of E-Da Hospital. All experiments were performed in accordance with relevant guidelines and regulations.

Study design {#Sec12}
------------

An 11-year retrospective study was conducted at a 1,000-bed university-affiliated hospital that serves more than 2 million people in southern Taiwan. A clinical laboratory database was searched to identify blood cultures that were identified as containing *Chryseobacterium* and *Elizabethkingia* species between January 2005 and December 2015. The isolates were initially identified as *Chryseobacterium* and *Elizabethkingia* species by a clinical microbiology laboratory that first used API/ID32 Phenotyping Kits (2005--2013) and then used a VITEK MS MALDI-TOF MS System (2014--2015) after upgrading the microbial identification system. All isolates were stored as glycerol stocks at −80 °C until used. *Chryseobacterium indologenes* BCRC 17271 (ATCC 29897) and *Elizabethkingia meningoseptica* BCRC 10677 (ATCC 13253) were used as quality controls. The 16S rRNA gene sequencing method was considered the reference method for bacterial identification.

16S rRNA gene sequencing {#Sec13}
------------------------

Frozen bacterial glycerol stocks were thawed and subcultured on tryptic soy agar with 5% sheep blood (Becton Dickinson Co., Sparks, MD, USA) for further experiments. Total DNA was isolated from each sample using a Wizard Genomic DNA Purification Kit according to the manufacturer's instructions (Promega, Madison, WI, USA). The primers used to amplify the internal fragments of the 16S rRNA gene were as described previously^[@CR18]^. Purified polymerase chain reaction (PCR) was performed using a GeneAmp PCR System 9700 (Applied Biosystems, Foster City, CA, USA). The PCR products were sequenced using an Applied Biosystems 3730xl DNA Analyzer (Applied Biosystems, Foster City, CA, USA). The primers used to sequence 16S16S rRNA were 8f (5′-GGATCCAGACTTTGATYMTGGCTCAG-3′), 534r (5′-ATTACCGCGGCTGCTGG-3′), 534f (5′-CCAGCAGCCGCGGTAAT-3′), 968f (5′-AACGCGAAGAACCTTAC-3′), and 1512r (5′-GTGAAGCTTACGGYTAGCTTGTTACGACTT-3′)^[@CR19]^. The sequences were reviewed and edited using Sequence Scanner v.1.0 (Applied Biosystems, Foster City, CA, USA). The obtained 16S rRNA sequences were compared to sequences in GenBank using the Basic Local Alignment Search Tool (<https://blast.ncbi.nlm.nih.gov/Blast.cgi>). The results were considered valid if the homologous rate was ≥99%.

Identification of microorganisms using microbial identification systems {#Sec14}
-----------------------------------------------------------------------

For re-identification, the thawed bacteria were inoculated on tryptic soy agar with 5% sheep blood after they were removed from the freezer. The plates were then incubated in a 5% CO~2~ atmosphere at 35 °C for 15 to 24 hours. All isolates were re-identified using API/ID32 Phenotyping Kits, Phoenix 100 ID/AST Automated Microbiology System, VITEK 2 Automated Identification System, and VITEK MS MALDI-TOF MS System. The isolates were identified according to each manufacturer's instructions. For the API/ID32 Phenotyping Kits, an ID 32 GN card and database version 3.1 were used to identify microorganisms according to ATB Expression. The results obtained using the Phoenix 100 ID/AST System were analyzed using database version 5.51 A. A confidence level of ≥90% was defined as acceptable for the Phoenix System^[@CR20]^. The identifications yielded by the VITEK 2 system were obtained using a GN ID card and database version 7.01. The quality of bacterial identification was assessed using VITEK 2 Advanced Expert System. The results were defined as acceptable at a confidence level of 96--99% (excellent identification) or 93--95% (very good quality)^[@CR21]^. The mass spectral fingerprints generated by the VITEK MS System were analyzed using Knowledge Base v2.0 and repeatedly tested using Knowledge Base v3.0. A confidence value of ≥90% (reliable identification) or 85%--90% (acceptable identification) was regarded as a successful identification. A value was defined as no identification if the VITEK MS confidence value was \<85%^[@CR22]^.

Data Availability {#Sec15}
-----------------

The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.
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